These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 15775250)

  • 1. [GH therapy in Prader-Willi syndrome].
    Ida S
    Clin Calcium; 2003 Dec; 13(12):1596-600. PubMed ID: 15775250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sustained benefit after 2 years of growth hormone on body composition, fat utilization, physical strength and agility, and growth in Prader-Willi syndrome.
    Myers SE; Carrel AL; Whitman BY; Allen DB
    J Pediatr; 2000 Jul; 137(1):42-9. PubMed ID: 10891820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth hormone therapy for Prader-Willi syndrome: a critical appraisal.
    Allen DB; Carrel AL
    J Pediatr Endocrinol Metab; 2004 Sep; 17 Suppl 4():1297-306. PubMed ID: 15506076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth hormone induced lipolysis during short- and long-term administration in adult Prader-Willi patients.
    Höybye C; Hilding A; Marcus C; Thorén M
    Growth Horm IGF Res; 2005 Dec; 15(6):411-5. PubMed ID: 16230042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prader-Willi syndrome: how does growth hormone affect body composition and physical function?
    Carrel AL; Allen DB
    J Pediatr Endocrinol Metab; 2001; 14 Suppl 6():1445-51. PubMed ID: 11837498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benefits of long-term GH therapy in Prader-Willi syndrome: a 4-year study.
    Carrel AL; Myers SE; Whitman BY; Allen DB
    J Clin Endocrinol Metab; 2002 Apr; 87(4):1581-5. PubMed ID: 11932286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prader-Willi syndrome. Treatment with growth hormone in 2 cases].
    Youlton R
    Rev Med Chil; 2001 Oct; 129(10):1186-90. PubMed ID: 11775347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Body composition in Prader-Willi syndrome compared with nonsyndromal obesity: Relationship to physical activity and growth hormone function.
    van Mil EG; Westerterp KR; Gerver WJ; Van Marken Lichtenbelt WD; Kester AD; Saris WH
    J Pediatr; 2001 Nov; 139(5):708-14. PubMed ID: 11713451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized controlled GH trial: effects on anthropometry, body composition and body proportions in a large group of children with Prader-Willi syndrome.
    Festen DA; de Lind van Wijngaarden R; van Eekelen M; Otten BJ; Wit JM; Duivenvoorden HJ; Hokken-Koelega AC
    Clin Endocrinol (Oxf); 2008 Sep; 69(3):443-51. PubMed ID: 18363884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive, emotional, physical and social effects of growth hormone treatment in adults with Prader-Willi syndrome.
    Höybye C; Thorén M; Böhm B
    J Intellect Disabil Res; 2005 Apr; 49(Pt 4):245-52. PubMed ID: 15816811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endocrine and metabolic aspects of adult Prader-Willi syndrome with special emphasis on the effect of growth hormone treatment.
    Höybye C
    Growth Horm IGF Res; 2004 Feb; 14(1):1-15. PubMed ID: 14700552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impairment of GH responsiveness to combined GH-releasing hormone and arginine administration in adult patients with Prader-Willi syndrome.
    Grugni G; Marzullo P; Ragusa L; Sartorio A; Trifirò G; Liuzzi A; Crinò A;
    Clin Endocrinol (Oxf); 2006 Oct; 65(4):492-9. PubMed ID: 16984242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth hormone treatment completely normalizes adult height and improves body composition in Prader-Willi syndrome: experience from KIGS (Pfizer International Growth Database).
    Lindgren AC; Lindberg A
    Horm Res; 2008; 70(3):182-7. PubMed ID: 18663319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current status of growth hormone therapy in Prader-Willi syndrome.
    Höybye C
    Expert Rev Endocrinol Metab; 2013 Nov; 8(6):529-536. PubMed ID: 30736137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth hormone treatment and adverse events in Prader-Willi syndrome: data from KIGS (the Pfizer International Growth Database).
    Craig ME; Cowell CT; Larsson P; Zipf WB; Reiter EO; Albertsson Wikland K; Ranke MB; Price DA;
    Clin Endocrinol (Oxf); 2006 Aug; 65(2):178-85. PubMed ID: 16886957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Five-years growth hormone (GH) treatment in adults with Prader-Willi syndrome.
    Höybye C
    Acta Paediatr; 2007 Mar; 96(3):410-3. PubMed ID: 17407467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endocrine dysfunction in Prader-Willi syndrome: a review with special reference to GH.
    Burman P; Ritzén EM; Lindgren AC
    Endocr Rev; 2001 Dec; 22(6):787-99. PubMed ID: 11739333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retrospective study of the potential benefits and adverse events during growth hormone treatment in children with Prader-Willi syndrome.
    Fillion M; Deal C; Van Vliet G
    J Pediatr; 2009 Feb; 154(2):230-3. PubMed ID: 18814886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early manifestations of Prader-Willi syndrome: influence of growth hormone.
    Eiholzer U; Schlumpf M; Nordmann Y; l'Allemand D
    J Pediatr Endocrinol Metab; 2001; 14 Suppl 6():1441-4. PubMed ID: 11837497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of NREM sleep in children with Prader-Willi syndrome and the effect of growth hormone treatment.
    Verrillo E; Bruni O; Franco P; Ferri R; Thiriez G; Pavone M; Petrone A; Paglietti MG; Crinò A; Cutrera R
    Sleep Med; 2009 Jun; 10(6):646-50. PubMed ID: 19027358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.